Professional
Added to YB: 2024-10-18
Pitch date: 2024-10-16
EW [bullish]
Edwards Lifesciences Corporation
+21.19%
current return
Author Info
No bio for this author
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$48.2B
Pitch Price
$68.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
24.80
P/E
36.34
EV/Sales
7.66
Sector
Health Care Equipment and Supplies
Category
growth
Wedgewood Partners Portfolio Holding: Edwards Lifesciences Corporation
EW: TAVR growth slowed, but market far from saturated. Clinical trials could drive acceleration. Added to position after sell-off, as forward earnings multiples fell to historical lows. Solid competitive positioning and pure-play focus on minimally invasive structural heart conditions support long-term double-digit earnings growth potential.
Read full article (1 min)